Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Oragenics, Inc. Closes Public Offering to Fund ONP-002 Product Candidate Development
Sep 05, 2024•almost 2 years ago
Contract Type
partnership
TampaBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Oragenics, Inc. has successfully closed a public offering of shares of its common stock and pre-funded warrants, generating approximately $4.45 million in gross proceeds. The company intends to use the proceeds to fund the continued development of its ONP-002 product candidate and for general corporate purposes and working capital.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months